http://www.prnewswire.com/news-releases/medtronic-outlines-growth-strategy-at-biennial-investor-day-301151771.html. RTG’s revenue decline this quarter reflected the impact of the COVID-19 pandemic and specifically, a decline in deferrable procedures and some impact from the reduction in customer bulk purchases and capital equipment purchases. "We have found a new gear at Medtronic. Our products treat 70 health conditions and our therapies help 75 million people a year. Non-U.S. developed market revenue of $2.218 billion represented 37 percent of company revenue and decreased 14 percent as reported and 11 percent constant currency. About Medtronic Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Webcast Information Medtronic will host a webcast of its virtual 2020 Investor Day today, Oct. 14, at 8:00 a.m. EDT (7:00 a.m. CDT) to provide access to all interested stakeholders. SI’s low-twenties decline was partially offset by high-single digit growth in RGR, both on a constant currency basis. About MedtronicMedtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. DUBLIN and SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared … Our employees come from varied backgrounds with a common goal—changing lives. The dividend is payable on July 17, 2020, to shareholders of record at the close of business on June 26, 2020. “Our financial position remains strong, and we’re differentially using our balance sheet during the pandemic. Medtronic will host a webcast of its virtual 2020 Investor Day today, Oct. 14, at 8:00 a.m. EDT (7:00 a.m. CDT) to provide access to all interested stakeholders. Ryan Weispfenning Investor Relations As reported, fiscal year 2020 net earnings were $4.789 billion or $3.54 per diluted share. This quarterly webcast can be accessed by clicking on the Investor Events link at investorrelations.medtronic.com and this earnings release will be archived at newsroom.medtronic.com.

At the virtual event, Martha and other members of Medtronic's executive and senior management team will provide an in-depth review of the company's growth agenda, which is underpinned by a pipeline of innovative and disruptive products launching now and over the coming years. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.-end- Erika Winkels Public Relations +1-763-526-8478. Webcast InformationMedtronic will host a webcast today, May 21, at 8:00 a.m. EDT (7:00 a.m. CDT) to provide information about its businesses for the public, investors, analysts, and news media.

Diabetes Group revenue performance was impacted by a delay in new patient starts on insulin pumps due to the closing of physician offices as a result of COVID-19. This is the company's first Investor Day since Chief Executive Officer Geoff Martha assumed the role in April 2020. "We have found a new gear at Medtronic. References to quarterly and annual figures increasing, decreasing or remaining flat are in comparison to fiscal year 2019. The power to improve lives.